Fig. 5. Suppressed TGFβ signaling in Lkb1-deficient
ECs. (A) Quantitative RT-PCR analysis of LKB1, TGFβ1 and PAI1
mRNA levels in immortalized HUVECs, or wild-type and Lkb1lox/-,
Tie1-Cre yolk sacs, as indicated. HUVECs were transfected with a
control-siRNA or two independent siRNAs targeting LKB1 (LKB1-si1 and
LKB1-si2). Measurements were normalized according to GAPDH mRNA levels and are
presented relative to control samples (control-siRNA transfected HUVECs or
wild-type yolk sac). Bars represent the mean (±s.d.) of two samples
(siRNA treated), four samples (control-siRNA) or three samples (yolk sacs;
*P<0.05, **P<0.01).
(B,C) pSMAD2 (red) and PECAM1 (brown) staining of E12 wild-type
(B) and Lkb1lox/-, Tie1-Cre (C) yolk sac sections.
(D,E) Higher magnifications of boxed areas in B and C.
(F) Percentage of pSMAD2-positive ECs and mesenchymal cells in
wild-type and Lkb1lox/-, Tie1-Cre yolk sacs, with means
(±s.d.) of three embryos indicated (*P<0.05). e,
endoderm; EC, endothelial cell; mes, mesenchymal cell.